Key Takeaways
- Rivian shares declined approximately 4% in premarket hours Friday following Q1 results, even after surpassing loss projections
- First-quarter revenue reached $1.38B, representing an 11% year-over-year increase; EPS loss of $0.33 significantly outperformed the $0.72 consensus
- R2 manufacturing commenced at the Normal, IL facility; initial customer shipments anticipated “later this spring”
- Department of Energy financing reduced from $6.6B to approximately $4.5B, while Georgia manufacturing site capacity boosted 50% to 300,000 vehicles
- Skeptical analyst cautions RIVN carries excessive valuation at $20B market capitalization given untested R2 market reception
Shares of Rivian (RIVN) retreated roughly 4% during Friday’s premarket session following the electric vehicle manufacturer’s first-quarter 2026 financial disclosure. Trading at $16.40 Wednesday’s close, the stock slipped to $15.76 in early Friday activity.
The financial results exceeded Wall Street’s more pessimistic projections. First-quarter revenue totaled $1.38 billion, reflecting an 11% year-over-year climb. The per-share loss of $0.33 substantially beat analyst consensus of $0.72.
The automaker reported $119 million in gross profit — marking the third straight quarter of positive gross profitability. Software and services emerged as a particularly strong performer, generating $180 million in gross profit, approximately 60% above the prior-year period.
However, adjusted EBITDA registered a negative $472 million. Profitability remains out of reach, a reality not lost on market participants.
Rivian manufactured 10,236 vehicles while delivering 10,365 units during the first quarter. Management maintained its full-year 2026 delivery target of 62,000 to 67,000 vehicles.
The R2 platform has entered production at the company’s Normal, Illinois manufacturing facility. CEO RJ Scaringe indicated customer deliveries will commence “later this spring,” with substantial volume increases expected during the third and fourth quarters.
“With the increase in volume, you have more fixed cost absorption, so the cost of goods sold will come down meaningfully,” Scaringe explained. “The margin structure will start to shine through.”
Georgia Manufacturing Facility Plan Revised
Rivian announced revised specifications for its planned Georgia production plant. Starting capacity will rise 50% to 300,000 units annually, with construction set to begin in 2026.
The Department of Energy loan backing the project has been adjusted downward from $6.6 billion to roughly $4.5 billion. However, Rivian will begin accessing these funds in 2027, advancing the previous 2028 schedule.
“Accessing those dollars sooner and faster is going to be helpful to get more capacity, more volume sooner,” Scaringe noted. Following Phase 1 completion, Rivian projects total production capacity exceeding 500,000 units — a threshold Scaringe believes enables positive free cash flow generation.
Cash Position Stable Despite Skepticism From Some Analysts
The company finished the first quarter with $4.83 billion in cash reserves and $5.39 billion in overall liquidity, down from $6.59 billion at year-end 2024. The reduction mirrors continued capital deployment as operations expand.
Scaringe highlighted a comprehensive liquidity framework totaling $13.6 billion when factoring in the Volkswagen joint venture capital, the Uber partnership, and DOE financing. In early 2026, Rivian secured an additional $1 billion from Volkswagen following successful testing of the VW ID.EVERY1, which incorporates Rivian’s software architecture and platform technologies.
The Uber agreement, finalized in March, commits Rivian to providing up to 50,000 autonomous R2 electric vehicles in return for $1.25 billion in funding.
Dissenting voices remain. Investment analyst ValueAnalyst maintains a Sell rating, contending the $20 billion market valuation already assumes R2 commercial success — despite critical specifications like range and final pricing remaining undisclosed. These details won’t emerge until late 2027, while short interest currently exceeds 11% of shares outstanding.
Wall Street consensus registers as Moderate Buy, comprising 10 Buy ratings, 8 Hold ratings, and 4 Sell ratings. The mean 12-month price objective stands at $17.91.


